I.G. Investment Management’s Charles River Laboratories CRL Stock Holding History

I.G. Investment Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$624K	Buy	+5,778	New	+$594K	﹤0.01%	386
2016 Q4	–	Sell	-18,362	Closed	-$1.53M	–	482
2016 Q3	$1.53M	Buy	18,362 +1,562	+9%	+$131K	0.01%	565
2016 Q2	$1.39M	Buy	16,800 +418	+3%	+$34.4K	0.01%	584
2016 Q1	$1.24M	Buy	16,382 +4,274	+35%	+$316K	0.01%	597
2015 Q4	$973K	Buy	12,108 +1,662	+16%	+$120K	﹤0.01%	648
2015 Q3	$664K	Buy	10,446 +346	+3%	+$24.8K	﹤0.01%	702
2015 Q2	$710K	Buy	10,100 +721	+8%	+$53.4K	﹤0.01%	706
2015 Q1	$744K	Buy	9,379 +170	+2%	+$12.5K	﹤0.01%	692
2014 Q4	$586K	Buy	9,209 +755	+9%	+$47.3K	﹤0.01%	715
2014 Q3	$505K	Buy	8,454 +380	+5%	+$21.7K	﹤0.01%	702
2014 Q2	$432K	Buy	8,074 +924	+13%	+$50.7K	﹤0.01%	743
2014 Q1	$431K	Buy	7,150 +150	+2%	+$8.74K	﹤0.01%	733
2013 Q4	$371K	Buy	7,000 +365	+6%	+$18.3K	﹤0.01%	727
2013 Q3	$307K	Buy	6,635 +65	+1%	+$2.98K	﹤0.01%	753
2013 Q2	$270K	Buy	+6,570	New	+$281K	﹤0.01%	750

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

I.G. Investment Management's CRL Position: Q3 2017 in Review

I.G. Investment Management opened a new position in Charles River Laboratories (CRL) in Q3 2017: 5,778 shares worth $624K. The stake represents ﹤0.01% of the portfolio and ranks #386 among its holdings. This is a return to the name: I.G. Investment Management previously reported a position in CRL as recently as Q3 2016.

I.G. Investment Management first reported a position in CRL in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.53M in Q3 2016. 336 funds tracked by Wall St. Rank hold CRL as of Q3 2017.

I.G. Investment Management held 5,778 shares of Charles River Laboratories worth $624K as of Q3 2017.
Charles River Laboratories was a new I.G. Investment Management position in Q3 2017.
Charles River Laboratories made up ﹤0.01% of I.G. Investment Management's portfolio in Q3 2017, its #386 holding.
I.G. Investment Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 15 quarters since.
I.G. Investment Management's Charles River Laboratories position peaked at $1.53M in Q3 2016.
336 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2017.

Based on I.G. Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.